Number of patients achieving a complete response (CR) 24 months [clinicaltrials_resource:b5557f94558ad365b61fbcd7d2773728]
Complete Response is defined as patients that stop intensive deferasirox -DFO treatment, at any time point during the 24 months of study, based on an improvement in the cardiac MRI T2* value being >10ms, and continue to be treated with deferasirox monotherapy without any further need for reverting back to intensive iron chelation treatment during the 24 months of study.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Number of patients achieving a complete response (CR) 24 months [clinicaltrials_resource:b5557f94558ad365b61fbcd7d2773728]
Complete Response is defined as patients that stop intensive deferasirox -DFO treatment, at any time point during the 24 months of study, based on an improvement in the cardiac MRI T2* value being >10ms, and continue to be treated with deferasirox monotherapy without any further need for reverting back to intensive iron chelation treatment during the 24 months of study.
Bio2RDF identifier
b5557f94558ad365b61fbcd7d2773728
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b5557f94558ad365b61fbcd7d2773728
measure [clinicaltrials_vocabulary:measure]
Number of patients achieving a complete response (CR)
time frame [clinicaltrials_vocabulary:time-frame]
description
Complete Response is defined a ...... during the 24 months of study.
identifier
clinicaltrials_resource:b5557f94558ad365b61fbcd7d2773728
title
Number of patients achieving a complete response (CR) 24 months
@en
type
label
Number of patients achieving a ...... 57f94558ad365b61fbcd7d2773728]
@en